These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6070564)

  • 1. [Clinical effect of Transamin, an antiplasmin agent, in otorhinolaryngology].
    Iwasawa T
    Jibiinkoka; 1967 Feb; 39(2):195-205. PubMed ID: 6070564
    [No Abstract]   [Full Text] [Related]  

  • 2. [A choice antihemorrhagic agent in infantile otorhinolaryngology: Capramol Choay (Epsilon-Aminocaproic acid)].
    Berger M; Pinson
    Rev Laryngol Otol Rhinol (Bord); 1966; 87(1):52-5. PubMed ID: 5908647
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical effect of Transamin in otorhinolaryngology--by double blind methods].
    Saito H; Ri D; Iizuka T; Yukawa
    Jibiinkoka; 1969 Jun; 41(6):455-60. PubMed ID: 4896403
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience in the use of the local hemostatic agent Kaprofer in otorhinolaryngologic practice].
    Dunaĭvitser BI; Gulunian EA; Lalaev KV; Manukian VM
    Vestn Otorinolaringol; 1987; (5):71-3. PubMed ID: 3424525
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical use of dexamethasone (Dectan) in otorhinolaryngology].
    Sato M; Hayakawa T; Abe K; Iwama S; Takeyama I
    Jibiinkoka; 1966 May; 38(5):549-55. PubMed ID: 5336147
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antihemorrhagic agent of choice in pediatric ENT: capramol Choay (epsilon-aminocaproic acid)].
    Berger M; Pinson
    J Med Bord; 1965 Apr; 142(4):719-21. PubMed ID: 5318696
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience with Ibunac in the field of otorhinolaryngology].
    Kashiwado T
    Jibiinkoka; 1968 Nov; 40(11):943-6. PubMed ID: 5752436
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical use of IP-82 in otorhinolaryngology].
    Sakamoto S; Kometani T; Ishimoda M; Takeuchi T; Saito H
    Jibiinkoka; 1970 Jul; 42(7):559-62. PubMed ID: 5466256
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolytic activity in hemophilia and the use of epsilon-aminocaproic acid.
    Ritz ND
    N Y State J Med; 1965 Dec; 65(23):2914-25. PubMed ID: 5320118
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of ketazone in otorhinolaryngology].
    Traissac L; Chabrol A
    Rev Laryngol Otol Rhinol (Bord); 1975; 96(5-6):341-7. PubMed ID: 1101334
    [No Abstract]   [Full Text] [Related]  

  • 11. [Advantages of a painless and colorless topical agent in otorhinolaryngology].
    Appaix A; Dinand F; Houel B
    Mars Med; 1971; 108(1):79-81. PubMed ID: 4323276
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with sulfamethopyrazine in the field of otorhinolaryngology].
    Takebayashi T; Yanagi Y; Katano F; Masuda Y
    Jibiinkoka; 1968 Dec; 40(12):1021-6. PubMed ID: 5752440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of epsilon-aminocaproic acid hydrochloride for the prevention of early hemorrhages after tonsillectomy].
    Timoshenskiĭ VI; Gerber VKh
    Vestn Otorinolaringol; 1968; 30(4):60-2. PubMed ID: 5740006
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of the analgesic and anti-inflammatory activity of AF-864 (benzydamine hydrochloride) in otorhinolaryngology].
    Di Fede S
    Policlinico Prat; 1966 Nov; 73(46):1540-5. PubMed ID: 5998755
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental and clinical evaluation of sulfiodizole in the field of otorhinolaryngology].
    Takasu K; Baba S; Mamiya A; Oashi M; Suzuki M
    Jibiinkoka; 1970 Dec; 42(12):1063-9. PubMed ID: 5529972
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of abboticine in otorhinolaryngology].
    Mounier-Kuhn P; Haguenauer JP; Bouchayer M
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Mar; 18(3):191-3. PubMed ID: 4245686
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic results of aminocyclohexyl-penicillin for the infectious diseases in otorhinolaryngology].
    Sanbe T; Murakami H; Takeuchi M; Nishizaki K; Jo K
    Jibiinkoka; 1970 Jan; 42(1):71-6. PubMed ID: 5461397
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of Veybirol-tyrothricin in otorhinolaryngology].
    Riu R; Alavoine J; Auriault A; Le Mouel C
    J Med Lyon; 1968 Jan; 49(135):91-103. PubMed ID: 5647287
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of niflumic acid in otorhinolaryngology].
    Portmann M; Pardes P
    Rev Laryngol Otol Rhinol (Bord); 1968; 89(7):494-8. PubMed ID: 5715347
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical biochemical justification for the use of fibrinolysis inhibitors in the therapy of hemorrhages in ENT diseases].
    Veremeenko KN; Gerasimenko NG; Pogorelova LM
    Zh Ushn Nos Gorl Bolezn; 1972; (3):56-61. PubMed ID: 4680879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.